StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 2/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.36MP/E –Yield –

CannaPharmaRx profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CannaPharmaRx's profit margin for the twelve months ending Jun 30, 2026 was -666.2%. For fiscal 2025 it was -817.2%, against -1207.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-817.2%+390.6
FY2024Dec 31, 2024-1207.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-691.1%−80.9
Q1 FY2026Mar 31, 2026-60.9%+145.1
Q4 FY2025Dec 31, 2025-5445.9%−4670.0
Q3 FY2025Sep 30, 2025-225.1%−285.4
Q2 FY2025Jun 30, 2025-610.3%+44730.6
Q1 FY2025Mar 31, 2025-206.0%–
Q4 FY2024Dec 31, 2024-775.9%–
Q3 FY2024Sep 30, 202460.4%–
Q1 FY2024Mar 31, 2024-45340.9%–

More CannaPharmaRx figures

See a number that looks wrong?